Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. - Concepedia

Concepedia

Publication | Open Access

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

DOI Full Paper Access

358

Citations

0

References

1996

Year

John H. Kehne, B M Baron, A A Carr, S. Chaney, Jack Elands, Daniel J. Feldman, Robert Frank, P L van Giersbergen, Timothy C. McCloskey, Martin Johnson,

Journal of Pharmacology and Experimental Therapeutics

No additional data available for this publication yet. Check back later!